Heterogeneity is a major challenge in cancer treatment, which has a profound impact on cancer evolution & metastasis and drug resistance. With the developments of new technologies, there emerge successive achievements with great significance on clinical therapeutics. This symposium will focus on cancer heterogeneity, promoting the clinical translation of research.
- Cancer Evolution, Cell Plasticity and Cancer Heterogeneity
- Cancer Heterogeneity Driven by CSC
- Chromosome Instability and Cancer Heterogeneity
- Effects of Tumor Microenvironment on Cancer Heterogeneity
- Study of Cancer Metastasis from the View of Cancer Evolution
-
- Dynamic Monitoring of Cancer Evolution and Heterogeneity
- Cancer Heterogeneity and Molecular Targeted Therapy
- Cancer Driver Gene Detection
- Case Studies of Cancer Evolution and Heterogeneity: Breast Cancer, Colon Cancer and Non-Small Cell Lung Cancer
- Primary and Acquired Drug Resistance
- Single Cell Capture and Sequencing
- Mutated Gene Detection by Digital PCR
- Multi-Omics Analysis
- CTC and cfDNA Liquid Biopsy
- SNP and CNV Analysis
-
-
-
Researchers from Universities and Institutes
Clinicians from Tumor Department and Other Departments
Personnels from the Firms providing the Laboratory Testing
Dear Mr./Ms.
You have registered successfully, the registration information and attention has been sent to the contact and the participants of the mailbox, please note that check. If not received, please contact the general meeting
